SI1294710T1 - Indole derivatives useful for the treatment of cns disorders - Google Patents
Indole derivatives useful for the treatment of cns disordersInfo
- Publication number
- SI1294710T1 SI1294710T1 SI200130395T SI200130395T SI1294710T1 SI 1294710 T1 SI1294710 T1 SI 1294710T1 SI 200130395 T SI200130395 T SI 200130395T SI 200130395 T SI200130395 T SI 200130395T SI 1294710 T1 SI1294710 T1 SI 1294710T1
- Authority
- SI
- Slovenia
- Prior art keywords
- treatment
- cns disorders
- indole derivatives
- derivatives useful
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200000919 | 2000-06-14 | ||
| US21244500P | 2000-06-16 | 2000-06-16 | |
| PCT/DK2001/000406 WO2001096328A1 (fr) | 2000-06-14 | 2001-06-13 | Derives indoliques utilises dans le traitement de troubles du systeme nerveux central (snc) |
| EP01940240A EP1294710B1 (fr) | 2000-06-14 | 2001-06-13 | Derives indoliques utilises dans le traitement de troubles du systeme nerveux central (snc) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1294710T1 true SI1294710T1 (en) | 2005-10-31 |
Family
ID=32912594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200130395T SI1294710T1 (en) | 2000-06-14 | 2001-06-13 | Indole derivatives useful for the treatment of cns disorders |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1468996B1 (fr) |
| DK (1) | DK1294710T3 (fr) |
| SI (1) | SI1294710T1 (fr) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA9711376B (en) * | 1996-12-20 | 1998-07-21 | Lundbeck & Co As H | Indole or dihydroindole derivatives |
| GB9718833D0 (en) * | 1997-09-04 | 1997-11-12 | Merck Sharp & Dohme | Therapeutic agents |
| GB9810886D0 (en) * | 1998-05-13 | 1998-07-22 | Lilly Industries Ltd | Pharmaceutical compounds |
| GB9825413D0 (en) * | 1998-11-19 | 1999-01-13 | Lilly Co Eli | Pharmaceutical compounds |
| CA2341542A1 (fr) * | 1999-06-24 | 2000-12-28 | Toray Industries, Inc. | Antagonistes du recepteur adrenergique-.alpha.1b |
| GB2362381A (en) * | 2000-05-18 | 2001-11-21 | Lilly Co Eli | Pharmaceutically active indolyl-piperidines |
| AR028685A1 (es) * | 2000-06-14 | 2003-05-21 | Lundbeck & Co As H | Derivados de indol |
-
2001
- 2001-06-13 EP EP04012325A patent/EP1468996B1/fr not_active Expired - Lifetime
- 2001-06-13 DK DK01940240T patent/DK1294710T3/da active
- 2001-06-13 SI SI200130395T patent/SI1294710T1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1468996B1 (fr) | 2007-09-26 |
| DK1294710T3 (da) | 2005-10-03 |
| EP1468996A1 (fr) | 2004-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL153425A0 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders | |
| HK1044944A1 (en) | 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders | |
| AU2002215047A1 (en) | Isoquinoline derivatives useful in the treatment of cns disorders | |
| AU7388101A (en) | Indole derivatives useful for the treatment of cns disorders | |
| HRP20030052A2 (en) | 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders | |
| IL153605A0 (en) | Indole derivatives useful for the treatment of cns disorders | |
| IL153254A0 (en) | Indole derivatives useful for the treatment of cns disorders | |
| IL142589A0 (en) | 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders | |
| IL154378A0 (en) | Compounds for the treatment of addictive disorders | |
| SI1468686T1 (sl) | S-metil-dihidro-ziprazidon za zdravljenje psihiatricnih motenj | |
| NO20026028D0 (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
| SG82014A1 (en) | The use of aryl-cyclohexylamine derivatives against cns disorders | |
| HK1059086A1 (en) | Indole derivatives useful for the treatment of cns disorders | |
| IL153351A0 (en) | Indole derivatives useful for the treatment of cns disorders | |
| SI1294710T1 (en) | Indole derivatives useful for the treatment of cns disorders | |
| SI1305307T1 (en) | Indole derivatives useful for the treatment of cns disorders | |
| AU6007900A (en) | Azetidine carboxamide derivatives for the treatment of cns disorders | |
| SI1309586T1 (sl) | Derivati 4-,5-,6- in 7-indola uporabni za zdravljenje motenj cns |